Edwards JCW - Search Results

1

Roy A, Perlovsky L, Besold TR, Weng J, Edwards JCW. Roy A, et al. Among authors: edwards jcw. Front Psychol. 2018 Aug 8;9:1410. doi: 10.3389/fpsyg.2018.01410. eCollection 2018. Front Psychol. 2018. PMID: 30135671 Free PMC article. No abstract available.

2

Distinguishing Representations as Origin and Representations as Input: Roles for Individual Neurons.

Edwards JC. Edwards JC. Front Psychol. 2016 Sep 30;7:1537. doi: 10.3389/fpsyg.2016.01537. eCollection 2016. Front Psychol. 2016. PMID: 27746760 Free PMC article.

3

The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem.

Edwards JC, McGrath S, Baldwin A, Livingstone M, Kewley A. Edwards JC, et al. Fatigue. 2016 Apr 2;4(2):63-69. doi: 10.1080/21641846.2016.1160598. Epub 2016 Apr 28. Fatigue. 2016. PMID: 27226928 Free PMC article. No abstract available.

4

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

Cambridge G, Perry HC, Nogueira L, Serre G, Parsons HM, De La Torre I, Dickson MC, Leandro MJ, Edwards JC. Cambridge G, et al. J Autoimmun. 2014 May;50:67-76. doi: 10.1016/j.jaut.2013.12.002. Epub 2013 Dec 22. J Autoimmun. 2014. PMID: 24365380

5

Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab.

de la Torre I, Leandro MJ, Edwards JC, Cambridge G. de la Torre I, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4):554-60. Epub 2012 Aug 29. Clin Exp Rheumatol. 2012. PMID: 22510323

6

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics.

De La Torre I, Leandro MJ, Valor L, Becerra E, Edwards JC, Cambridge G. De La Torre I, et al. Rheumatology (Oxford). 2012 May;51(5):833-40. doi: 10.1093/rheumatology/ker417. Epub 2012 Jan 16. Rheumatology (Oxford). 2012. PMID: 22253030

7

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.

Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA. Lu TY, et al. Arthritis Rheum. 2009 Apr 15;61(4):482-7. doi: 10.1002/art.24341. Arthritis Rheum. 2009. PMID: 19333973 Free article.

8

Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy.

Sultan SM, Ng KP, Edwards JC, Isenberg DA, Cambridge G. Sultan SM, et al. Clin Exp Rheumatol. 2008 Sep-Oct;26(5):887-93. Clin Exp Rheumatol. 2008. PMID: 19032824 Clinical Trial.

9

Lymphoid follicles in joints: what do they mean?

Edwards JC, Leandro MJ. Edwards JC, et al. Arthritis Rheum. 2008 Jun;58(6):1563-5. doi: 10.1002/art.23506. Arthritis Rheum. 2008. PMID: 18512771 Free article. No abstract available.

10

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W. Cambridge G, et al. Ann Rheum Dis. 2008 Jul;67(7):1011-6. doi: 10.1136/ard.2007.079418. Epub 2007 Oct 25. Ann Rheum Dis. 2008. PMID: 17962238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page